ExoCoBio

Seoul, South Korea · Founded 2017 · Privately Held (backing)

Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. ExoCoBio is based in Seoul, South Korea and was founded in 2017. Its last known valuation is $510,000. It has raised $55.3 million.

Last price · $/share
—
Implied valuation
$510K
Total raised
$55.3M
Last round
—

Who backs ExoCoBio?

20 investors
InvestorType
SBI InvestmentVenture capital
Korea Investment PartnersVenture capital
InterVestVenture capital
KDB CapitalOther
T.S. InvestmentVenture capital
K2 Investment PartnersVenture capital
Quantum Ventures KoreaVenture capital
TKG VenturesVenture capital
HLB BioStep CompanyOther
CSquared Global Asset ManagementHedge fund
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ExoCoBio investors

20 investors are on record for ExoCoBio, including SBI Investment, Korea Investment Partners, InterVest and KDB Capital. By type, the record holds 7 venture capital firms and 1 hedge fund.

Free account
More of ExoCoBio with a free account
  • ·The complete investor list: 20 names
  • ·Watch ExoCoBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like ExoCoBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View